Observational studyAdvances in therapy2024

Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study.

Amita Ketkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.